DK0643838T3 - Fremgangsmåde til påvisning af antistoffer hos seronegative individer - Google Patents

Fremgangsmåde til påvisning af antistoffer hos seronegative individer

Info

Publication number
DK0643838T3
DK0643838T3 DK93900599T DK93900599T DK0643838T3 DK 0643838 T3 DK0643838 T3 DK 0643838T3 DK 93900599 T DK93900599 T DK 93900599T DK 93900599 T DK93900599 T DK 93900599T DK 0643838 T3 DK0643838 T3 DK 0643838T3
Authority
DK
Denmark
Prior art keywords
hiv
individuals
whole blood
detecting antibodies
seronegative
Prior art date
Application number
DK93900599T
Other languages
English (en)
Inventor
Steven J Cohen
Tamar Jehuda-Cohen
Original Assignee
Shiloov Medical Technologies L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiloov Medical Technologies L filed Critical Shiloov Medical Technologies L
Application granted granted Critical
Publication of DK0643838T3 publication Critical patent/DK0643838T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
DK93900599T 1991-11-25 1992-11-24 Fremgangsmåde til påvisning af antistoffer hos seronegative individer DK0643838T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79773091A 1991-11-25 1991-11-25
PCT/US1992/010075 WO1993011435A1 (en) 1991-11-25 1992-11-24 Method and kit for the detection of antibodies in seronegative individuals

Publications (1)

Publication Number Publication Date
DK0643838T3 true DK0643838T3 (da) 2000-09-11

Family

ID=25171653

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93900599T DK0643838T3 (da) 1991-11-25 1992-11-24 Fremgangsmåde til påvisning af antistoffer hos seronegative individer

Country Status (13)

Country Link
US (2) US5637453A (da)
EP (1) EP0643838B1 (da)
JP (2) JPH07509557A (da)
AT (1) ATE191791T1 (da)
CA (2) CA2124319A1 (da)
DE (1) DE69230918T2 (da)
DK (1) DK0643838T3 (da)
ES (1) ES2147195T3 (da)
GR (1) GR3033919T3 (da)
IL (2) IL103852A (da)
PT (1) PT643838E (da)
WO (1) WO1993011435A1 (da)
ZA (1) ZA929160B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
JP2001504233A (ja) * 1996-11-22 2001-03-27 シルーヴ メディカル テクノロジーズ リミテッド 癌を有する被験者の早期検出のための全血／マイトジェンアッセイおよびキット
EP0973944A1 (en) * 1997-03-31 2000-01-26 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
WO1998044160A1 (en) * 1997-03-31 1998-10-08 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
GB9913819D0 (en) 1999-06-14 1999-08-11 Plasmacute As Assay
DE10125730A1 (de) * 2001-05-17 2002-11-21 A I D Autoimmun Diagnostika Gm Verfahren zum Nachweis von Erregern und durch diese induzierten zellulär produzierten Stoffen im lebenden Organismus
EP1624785B1 (en) * 2003-01-17 2013-07-17 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
EP2295974A1 (en) 2004-09-08 2011-03-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Compositions and methods for the detection of HIV-1/HIV-2 infection
US7770050B2 (en) * 2006-05-03 2010-08-03 Sony Computer Entertainment Inc. Method and apparatus for resolving clock management issues in emulation involving both interpreted and translated code
WO2012032512A2 (en) * 2010-09-07 2012-03-15 Smart Biotech Ltd. Methods and kits for the detection of an infection in subjects with low specific antibody levels
BR112013024317A2 (pt) * 2011-03-23 2019-09-24 Smart Biotech Ltd método e kit para a determinação do tempo de seroconversão de um paciente infectado com um vírus
US20150330980A1 (en) * 2012-03-08 2015-11-19 Smart Biotech Ltd. Methods and kits for the detection of viral infections
WO2013132502A1 (en) * 2012-03-08 2013-09-12 Smart Biotech Ltd. Method and kit for the detection of hepatitis-specific antibodies
WO2016014861A1 (en) * 2014-07-25 2016-01-28 Incelldx, Inc. Methods of evaluating a cellular sample for latent cellular replication competent hiv-1, and compositions and kits for use in practicing the same
DE102019214137A1 (de) * 2019-09-17 2021-03-18 Hot Screen Gmbh Verwendung in vitro eines Kits und eines Verfahrens zur Diagnostik von Transplantationen und/oder Autoimmunerkrankungen und/oder Tumorerkrankungen und/oder Vakzinierungen sowie ein botenstoffhaltiger Überstand, zellhaltiges Sediment und eine Kombination zur Anwendung bei der Diagnostik von Transplantationen und/oder Autoimmunerkrankungen und/oder Tumorerkrankungen und/oder Vakzinierungen
CN113917162B (zh) * 2021-12-14 2022-04-01 江苏为真生物医药技术股份有限公司 去唾液酸糖蛋白受体片段sH2a作为标志物的应用

Also Published As

Publication number Publication date
DE69230918T2 (de) 2000-11-09
PT643838E (pt) 2000-10-31
JPH07509557A (ja) 1995-10-19
EP0643838B1 (en) 2000-04-12
IL103852A0 (en) 1993-04-04
WO1993011435A1 (en) 1993-06-10
IL125330A0 (en) 1999-08-17
IL103852A (en) 1999-06-20
EP0643838A4 (en) 1996-02-28
GR3033919T3 (en) 2000-11-30
DE69230918D1 (de) 2000-05-18
US5637453A (en) 1997-06-10
CA2200363A1 (en) 1993-05-26
US20020006608A1 (en) 2002-01-17
ES2147195T3 (es) 2000-09-01
CA2124319A1 (en) 1993-06-10
ATE191791T1 (de) 2000-04-15
ZA929160B (en) 1993-08-16
EP0643838A1 (en) 1995-03-22
JPH11237381A (ja) 1999-08-31

Similar Documents

Publication Publication Date Title
DK0643838T3 (da) Fremgangsmåde til påvisning af antistoffer hos seronegative individer
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
FI942369A (fi) Hepatitis-C-virustesti
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
DE69131707D1 (de) Nachweis von Hepatits C mit Verwendung rekombinanter Antigene
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
KR920701481A (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
Dittmar et al. Monoclonal antibodies specific for dengue virus type 3
ATE167522T1 (de) Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen
Walther et al. Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies
ATE178096T1 (de) Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
DK1044377T3 (da) Fremgangsmåde til påvisning af Borna disease virus (BDV)-infektioner
Cammack et al. Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays
EP0402757A3 (de) Festphasenimmunoassay und Testbesteck zur Bestimmung von Antigenen und Antikörpern
Laperche et al. Comparative evaluation of the Geenius HCV supplemental assay and Inno-LIA HCV score assay in detecting anti-HCV antibodies
Gandhi et al. A simple spot-test for circulating Entamoeba histolytica antigen-antibody complexes in patients with amoebic
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
UA23988A (uk) Спосіб діагhостики сhіду
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
UA36086A (uk) Тест-система для підтвердження наявності антитіл проти вірусу гепатиту с (іфа-п-hcv)
RU97122081A (ru) Диагностика вируса с(+)-цепью рнк с использованием выделенного непроцессированного полипептида и вакцинация против этого вируса
WO2000004383A3 (en) Hiv group o positive control